Do thyroid hormones regulate vitamin D metabolism, and should patients with hypothyroidism or hyperthyroidism be screened for vitamin D deficiency and supplemented if needed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thyroid Hormones and Vitamin D: The Metabolic Relationship

Thyroid hormones do not directly regulate vitamin D metabolism, but they significantly affect bone and mineral metabolism through mechanisms that indirectly impact vitamin D status and requirements. The relationship is complex and bidirectional, with thyroid dysfunction altering calcium-phosphate homeostasis in ways that affect vitamin D metabolism 1.

How Thyroid Hormones Affect Mineral and Vitamin D Metabolism

Thyroid hormones stimulate bone resorption directly, which increases serum calcium and phosphorus concentrations. This elevation in calcium subsequently suppresses both parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D3 (the active form of vitamin D) 1. The mechanism works as follows:

  • In hyperthyroidism: Accelerated bone turnover leads to increased calcium release, which suppresses PTH and consequently reduces 1,25(OH)2D3 production 1
  • In hypothyroidism: The opposite effects occur, with reduced bone turnover and altered mineral homeostasis 1

Vitamin D Deficiency in Thyroid Disease

Vitamin D deficiency is highly prevalent in patients with thyroid disorders, but this appears to be an association rather than direct hormonal regulation. Multiple mechanisms contribute to low vitamin D levels in thyroid disease:

  • Accelerated vitamin D metabolism occurs in hyperthyroidism due to increased metabolic rate 2
  • Poor intestinal absorption of vitamin D can occur in thyrotoxicosis 2
  • Increased demand during bone restoration phases depletes vitamin D stores 2
  • Patients with hypothyroidism have significantly lower 25(OH)D levels compared to healthy controls (mean difference statistically significant, P=0.000) 3

Clinical Implications for Screening and Supplementation

All patients with hypothyroidism should be screened for vitamin D deficiency, as hypovitaminosis D is significantly associated with the degree and severity of hypothyroidism. The evidence supports routine screening and supplementation:

For Hypothyroid Patients:

  • Screen 25(OH)D levels in all hypothyroid patients, as vitamin D deficiency (<20 ng/mL) is common and associated with hypocalcemia 3
  • Vitamin D supplementation is advisable for hypothyroid patients with documented deficiency, as the severity of deficiency correlates with hypothyroidism severity 3
  • Monitor serum calcium levels alongside vitamin D, as hypothyroid patients often have concurrent hypocalcemia 3

For Hyperthyroid Patients:

  • Check 25(OH)D levels in patients with thyrotoxicosis, especially those with hypercalcemia, as the coexistence of hypercalcemia and vitamin D deficiency is possible but rare 2
  • Vitamin D supplementation may be needed during the bone restoration phase after treatment of hyperthyroidism 2
  • Bone markers (carboxy terminal collagen crosslink and procollagen type I N-terminal propeptide) are elevated in hyperthyroid patients, indicating high bone turnover 4

Important Caveats and Pitfalls

The relationship between vitamin D and thyroid function remains incompletely understood, with inconsistent study results. Key limitations include:

  • No consistent correlation exists between serum 25(OH)D levels and thyroid hormone levels across all studies 4, 5
  • Anti-thyroid antibody levels show variable associations with vitamin D status—some studies show negative correlation, others show no association 5
  • Vitamin D supplementation consistently reduces anti-thyroid antibody levels in most intervention studies, suggesting a potential immunomodulatory role 5

The primary treatment for hypercalcemia in thyrotoxicosis is correction of thyroid function, not vitamin D manipulation. Hypercalcemia in hyperthyroidism results from bone resorption and is confirmed by low PTH levels and resolution with thyroid treatment 2.

Vitamin D deficiency should be defined as 25(OH)D <20 ng/mL, with insufficiency at 20-30 ng/mL. Target levels should be ≥30 ng/mL for optimal bone health 6.

References

Research

Mineral and bone metabolism in thyroid disease: a review.

The Quarterly journal of medicine, 1986

Research

An unusual case of hypercalcemia associated with graves' disease and vitamin d deficiency.

Clinical medicine insights. Endocrinology and diabetes, 2011

Research

Vitamin d deficiency and its association with thyroid disease.

International journal of health sciences, 2013

Research

Vitamin D and the Thyroid: A Critical Review of the Current Evidence.

International journal of molecular sciences, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the appropriate management for a patient with hypothyroidism indicators, vitamin D insufficiency, potential dehydration, and mildly elevated bilirubin level?
What is the best course of treatment for a 20-year-old female patient with a history of hyperthyroidism, currently experiencing chronic fatigue, weight loss, extensive hair loss, feeling cold, and short menstrual periods, with lab results showing elevated Thyroid-Stimulating Hormone (TSH) levels, low iron saturation, and vitamin D deficiency, while taking birth control pills?
Are thyroid function tests and vitamin D (25-hydroxyvitamin D) tests indicated for routine screening in a well adult female exam?
Can vitamin D (Vitamin D) insufficiency cause suppressed Thyroid-Stimulating Hormone (TSH) levels?
In a 49-year-old woman with persistent mild hypercalcemia and vitamin D deficiency, should low-dose vitamin D supplementation be started while awaiting parathyroid hormone results?
What are the potential adverse effects and contraindications of soy isoflavone supplementation?
What is the appropriate workup for a patient presenting with hand numbness?
What is the recommended management for a comminuted fracture of the second metacarpal with dorsal angulation?
A 57-year-old woman with hypertension, hyperparathyroidism, migraine headaches, and prior gastric bypass surgery presents with progressive swelling from the right ear to the base of the neck, right facial fullness, marked fatigue, night sweats, intermittent nausea, and vertigo. What are the differential diagnoses and what urgent work‑up and management should be pursued?
In a patient with unexplained jugular venous distension, should a transthoracic echocardiogram (TTE) be obtained promptly?
What are the side effects of Victoza (liraglutide) and how should they be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.